Table 7.
Liver Function Indexes Before and After First DEB-TACE Therapy
| Liver Function Indexes | VL Patients (n=49) | Non-VL Patients (n=237) | P value |
|---|---|---|---|
| ALT (U/L), mean±SD | |||
| Before DEB-TACE | 47.4±41.2 | 49.7±29.1 | 0.711 |
| 1 day after DEB-TACE | 171.5±87.2 | 182.9±78.4 | 0.364 |
| 7 days after DEB-TACE | 75.2±33.6 | 71.4±39.9 | 0.534 |
| 1 month after DEB-TACE | 39.1±18.9 | 45.9±32.0 | 0.152 |
| AST (U/L), mean±SD | |||
| Before DEB-TACE | 49.50±27.2 | 44.2±21.7 | 0.082 |
| 1 day after DEB-TACE | 163.6±56.5 | 161.7±67.2 | 0.832 |
| 7 days after DEB-TACE | 81.1±36.1 | 89.4±44.7 | 0.223 |
| 1 month after DEB-TACE | 57.4±35.1 | 54.1±38.7 | 0.581 |
| ALB (g/L), mean±SD | |||
| Before DEB-TACE | 35.7±4.9 | 36.1±4.5 | 0.577 |
| 1 day after DEB-TACE | 31.9±5.5 | 30.9±5.0 | 0.212 |
| 7 days after DEB-TACE | 33.4±5.2 | 32.8±4.8 | 0.433 |
| 1 month after DEB-TACE | 37.5±5.0 | 37.9±4.5 | 0.579 |
Note: Comparison was determined by Student’s t test.
Abbreviations: DEB-TACE, drug-eluting beads transarterial chemoembolization; VL, vascular lake; ALT, alanine aspartate aminotransferase; SD, standard deviation; AST, aspartate aminotransferase; ALB, albumin.